Fayez Sarofim & CO Abb Vie Inc. Transaction History

Fayez Sarofim & CO

$36.5 Billion
Q2 2024

A detailed history of Fayez Sarofim & CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Fayez Sarofim & CO holds 2,028,833 shares of ABBV stock, worth $401 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

2,028,833

Previous 1,925,124 5.39%

Holding current value

$401 Million

Previous $351 Million 0.74%

% of portfolio

0.95%

Previous 1.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $16.1 Million - $18.7 Million	103,709 Added 5.39%	2,028,833 $348 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $1.3 Million - $1.48 Million	-8,122 Reduced 0.42%	1,925,124 $351 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $8.97 Million - $10.1 Million	-65,209 Reduced 3.26%	1,933,246 $300 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $11.7 Million - $13.5 Million	87,539 Added 4.58%	1,998,455 $298 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $21.6 Million - $26.9 Million	-163,187 Reduced 7.87%	1,910,916 $257 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $7.72 Million - $8.89 Million	53,400 Added 2.64%	2,074,103 $331 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $25.1 Million - $30.1 Million	-181,557 Reduced 8.24%	2,020,703 $327 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $632,800 - $725,779	-4,715 Reduced 0.21%	2,202,260 $296 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $1.23 Million - $1.57 Million	-8,973 Reduced 0.4%	2,206,975 $338 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $1.07 Million - $1.33 Million	8,113 Added 0.37%	2,215,948 $359 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $1.47 Million - $1.86 Million	13,674 Added 0.62%	2,207,835 $299 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $22.9 Million - $26 Million	-215,203 Reduced 8.93%	2,194,161 $237 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $55.9 Million - $62.3 Million	-531,664 Reduced 18.08%	2,409,364 $271 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $12.2 Million - $13.4 Million	-118,969 Reduced 3.89%	2,941,028 $318 Million
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $9.74 Million - $13.1 Million	-121,006 Reduced 3.8%	3,059,997 $328 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $21.5 Million - $25.2 Million	-250,243 Reduced 7.29%	3,181,003 $279 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $28.2 Million - $37.8 Million	384,878 Added 12.63%	3,431,246 $337 Million
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $9.47 Million - $14.4 Million	-146,775 Reduced 4.6%	3,046,368 $232 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $6.88 Million - $8.61 Million	-95,360 Reduced 2.9%	3,193,143 $283 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $3.91 Million - $4.71 Million	-62,150 Reduced 1.85%	3,288,503 $249 Million
Q2 2019 Aug 09, 2019	SELL	$65.7 - $83.98 $3.5 Million - $4.47 Million	-53,203 Reduced 1.56%	3,350,653 $244 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $2.46 Million - $2.9 Million	-31,924 Reduced 0.93%	3,403,856 $274 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $3.31 Million - $4.08 Million	-42,483 Reduced 1.22%	3,435,780 $317 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $5.03 Million - $5.59 Million	-56,550 Reduced 1.6%	3,478,263 $329 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $7.89 Million - $9.33 Million	-87,843 Reduced 2.42%	3,534,813 $328 Million
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $4.17 Million - $5.58 Million	45,297 Added 1.27%	3,622,656 $343 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $11.6 Million - $12.7 Million	-129,544 Reduced 3.49%	3,577,359 $346 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $259 Million - $331 Million	3,706,903	3,706,903 $329 Million

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account